Rendering of Lilly's forthcoming manufacturing site in Alzey, Germany (Credit: Eli Lilly)

November 17, 2023 10:29 AM EST

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Eli Lilly is set to build a new $2.5 billion facility in Germany to increase manufacturing capacity for its blockbuster diabetes and obesity drugs, and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Pfizer looking to sell hospital drugs unit — reports

'Expertise is a real thing': FDA commissioner warns of political risk to agency

AstraZeneca CEO reaffirms commitment to China following executive's detention

Merck, AstraZeneca tout Phase 3 win for cancer-turned-rare disease drug

Sanofi, OpenAI, Formation Bio debut patient recruiting tool, will use in Phase 3 multiple sclerosis studies

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

Lil­ly in­vests $2.5B in new Ger­man site to boost tirzepatide sup­ply, $100M for lo­cal biotechs

News Reporter

Senior Reporter

Sign up to read this article for free.

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs